Table of Content




1. Executive Summary


2. Global Adult Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Adult Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Adult Vaccine Market by Technology
3.3.1: Live Attenuated
3.3.2: Inactivated
3.3.3: Subunit
3.3.4: Toxoid
3.3.5: Conjugate
3.3.6: Others

3.4: Global Adult Vaccine Market by Vaccine Type
3.4.1: Monovalent
3.4.2: Multivalent

3.5: Global Adult Vaccine Market by End Use
3.5.1: Private Healthcare Firms
3.5.2: Government Hospitals





4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Adult Vaccine Market by Region
4.2: North American Adult Vaccine Market
4.2.1: North American Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
4.2.2: North American Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals

4.3: European Adult Vaccine Market

4.3.1: European Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
4.3.2: European Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals

4.4: APAC Adult Vaccine Market

4.4.1: APAC Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
4.4.2: APAC Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals

4.5: ROW Adult Vaccine Market

4.5.1: ROW Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
4.5.2: ROW Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Adult Vaccine Market by Technology
6.1.2: Growth Opportunities for the Global Adult Vaccine Market by Vaccine Type
6.1.3: Growth Opportunities for the Global Adult Vaccine Market by End Use

6.1.4: Growth Opportunities for the Global Adult Vaccine Market by Region

6.2: Emerging Trends in the Global Adult Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Adult Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adult Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Glaxosmithkline
7.2: Merck & CO
7.3: Sanofi
7.4: Johnson & Johnson
7.5: Serum institute India
7.6: AstraZeneca
7.7: Novartis